Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2
Open Access
- 1 March 2011
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 4 (2), 203-211
- https://doi.org/10.1242/dmm.006304
Abstract
SUMMARY The matrix metalloproteinase (MMP) family of extracellular proteases performs crucial roles in development and repair of the skeleton owing to their ability to remodel the extracellular matrix (ECM) and release bioactive molecules. Most MMP-null skeletal phenotypes that have been previously described are mild, thus permitting the assessment of their functions during bone repair in the adult. In humans and mice, MMP2 deficiency causes a musculoskeletal phenotype. In this study, we assessed the role of MMP2 during mouse fracture repair and compared it with the roles of MMP9 and MMP13. Mmp2 was expressed at low levels in the normal skeleton and was broadly expressed in the fracture callus. Treatment of wild-type mice with a general MMP inhibitor, GM6001, caused delayed cartilage remodeling and bone formation during fracture repair, which resembles the defect observed in Mmp9–/– mice. Unlike Mmp9- and Mmp13-null mutations, which affect both cartilage and bone in the callus, the Mmp2-null mutation delayed bone remodeling but not cartilage remodeling. This remodeling defect occurred without changes in either osteoclast recruitment or vascular invasion of the fracture callus compared with wild type. However, we did not detect changes in expression of Mmp9, Mmp13 or Mt1-Mmp (Mmp14) in the calluses of Mmp2-null mice compared with wild type by in situ hybridization, but we observed decreased expression of Timp2 in the calluses of Mmp2-, Mmp9- and Mmp13-null mice. In keeping with the skeletal phenotype of Mmp2-null mice, MMP2 plays a role in the remodeling of new bone within the fracture callus and impacts later stages of bone repair compared with MMP9 and MMP13. Taken together, our results indicate that MMPs play unique and distinct roles in regulating skeletal tissue deposition and remodeling during fracture repair.This publication has 28 references indexed in Scilit:
- Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formationDisease Models & Mechanisms, 2010
- Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal RegenerationPLOS ONE, 2007
- Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growthHuman Molecular Genetics, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Regulation of matrix biology by matrix metalloproteinasesCurrent Opinion in Cell Biology, 2004
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- In Vivo Inhibition of Osteoblastic Metalloproteinases Leads to Increased Trabecular Bone MassJournal of Bone and Mineral Research, 2004
- Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokinesThe FASEB Journal, 2004
- Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesisThe Journal of cell biology, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002